Skip to content
Magazine
Sunday, August 3, 2025
SUBSCRIBE
  • About Us
  • Belgium News
    • Belgium Police News
    • Brussels News
  • EU Institutions News
    • European Commission News
    • European Parliament News
    • European Council News
  • Europe News
  • World News
  • Belgium Business News
  • Culture and Society News
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Sustainable Perspective
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
  • About Us
  • Belgium News
    • Belgium Police News
    • Brussels News
  • EU Institutions News
    • European Commission News
    • European Parliament News
    • European Council News
  • Europe News
  • World News
  • Belgium Business News
  • Culture and Society News
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Sustainable Perspective
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
SUBSCRIBE

COVID-19 —EU mobilises aid to India but rejects vaccine IP waiver

Marta Pacheco by Marta Pacheco
6 May 2021
in EU Institutions News

Brussels (Brussels Morning) The European Commission is to mobilise an additional 2.2 billion euro to support India as it struggles to cope with the drastic surge of COVID-19 cases. The EU’s executive announcement comes a week after the European Parliament’s rejected a proposal to suspend COVID-19 vaccines intellectual property (IP) waivers for India and South Africa.

MEP José Gusmāo (GUE-NGL) described the Parliament’s vote rejecting the vaccine IP waiver as “disappointing”.

The amendment was rejected on 28 April by 454 votes to 162. With few exceptions, the centre-right European People’s Party (EPP), the socialists (S&D) and the liberals (Renew Europe) voted against the proposal.

“A vote to remember when these parties lament the slowness of vaccination or the appearance of variants from other continents, where vaccination has barely begun and where the virus runs free”, Gusmāo tweeted.

Meanwhile, the additional funding announced by the Commission will support a World Health Organisation (WHO) six-month case management programme for COVID-19 patients, in addition to strengthening laboratory capacity for COVID-19 testing. 

“We are providing additional EU support towards the fight against COVID-19 in India. This comes on top of the generous and swift assistance from EU member states that stepped up as part of Team Europe to offer critical supplies of oxygen, ventilators and medicines over the last few days”, Commissioner for Crisis Management, Janez Lenarčič, announced in a 5 May press statement. 

India appealed for a suspension of IP rights for COVID-19 treatments and vaccines in a proposal it submitted to the World Trade Organisation (WTO) a year ago, a request that since gained the support of more than 100 countries.

The EPP group in the Parliament expressed “fully agreement” that vaccinations needed to speed up in developing countries, but claimed that while “waiving the intellectual property rights looks like a good solution, it is not”.

US supports IP waiver

The US had declared its support for a COVID-19 vaccine IP waiver to help end the pandemic.

“These extraordinary times and circumstances call for extraordinary measures”, US Trade Ambassador Katherine Tai, declared in announcing that the US will participate in WTO negotiations to make that happen.

With the rich nations having acquired most of the global supply of COVID-19 doses, US President Joe Biden has come under increasing pressure to agree to waivers so that vaccine manufacturers can ramp up production and increase vaccine distribution to more countries.

Related News:

  • EU doubts value of COVID-19 vaccine IP waiver as WTO wavers
  • Parliament does U-turn on COVID-19 vaccines IP waiver
  • EU mobilises support to fight wildfires in Italy, Greece, Albania and North Macedonia
  • EC, India to launch EU-India Trade and Technology Council
Tags: Biweekly MartaBrussels DirectNews
Next Post

The world must act on China’s Uyghur genocide

Latest post

EU-elections-UK

EU elections: UK looks on from the “outside”

1 year ago
Galeries-Royales-Saint-Hubert

What Makes Galeries Royales Saint-Hubert an “Institution”?

1 year ago

Most Read

    Follow Brussels Morning
    Facebook Twitter Youtube Linkedin

    Browse Important News

    Belgium News
    Brussels News
    Culture and Society News
    Economy News
    EU Institutions News
    European Commission News
    European Council News
    European Parliament News
    Europe News
    Health And Fitness News
    Southeast Europe News
    Sustainable Perspective
    World News
    Diplomacy News
    US Elections News

    About Us

    Brussels Morning is a daily online newspaper based in Belgium. BM publishes unique and independent coverage on international and European affairs. With a Europe-wide perspective, BM covers policies and politics of the EU, significant Member State developments, and looks at the international agenda with a European perspective.

    More Info

    • About Us
    • Advertise With Us
    • Contact Us
    • Cookies Policy

    Join Our Newsletter

    Brussels Morning Newspaper – All Rights Reserved © 2024

    No Result
    View All Result
    • Home
    • About Us
    • Belgium News
      • Belgium Police News
      • Brussels News
    • Brussels Bubble
      • European Parliament News
      • European Commission News
      • European Council News
    • Wider Europe
      • Member States
    • World News
    • Business & Society
    • Europe With Transparency
    • Culture & Society
    • Policy Talks
      • Place de la Bourse
      • The Macro-Economist
      • Sustainable Perspective
      • Ambassador’s Corner
      • The American Angle
      • Southeast Europe
    • Print Magazine

    Brussels Morning Newspaper - All Rights Reserved © 2020

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
    Cookie settingsACCEPT
    Privacy & Cookies Policy

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
    Non-necessary
    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
    SAVE & ACCEPT